PPARA and obesity disorder: In the present study, the administration of a HFD during pregnancy led to decreased expression of Pparα in foetal livers, possibly by inhibiting the demethylation of Pparα‐dependent fatty acid oxidation–related genes and ultimately inhibiting lipid catabolism and inducing obesity.